Latest Breaking News On - Eisbach bio gmb - Page 1 : vimarsana.com

Omics Lab Services Market Report 2024 - Innovations in Genomics and Big Data Analytics

/PRNewswire/ -- The "Omics Lab Services Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering. The omics lab...

Adrenomed appoints Dr. med. Steffen Stürzebecher as Chief Medical Officer

DGAP-News: Adrenomed AG / Key word(s): PersonnelAdrenomed appoints Dr. med. Steffen Stürzebecher as Chief Medical Officer 23.06.2022 / 09:00 The issuer is solely responsible for the content of this announcement.Press ReleaseAdrenomed appoints Dr. med. Steffen Stürzebecher as Chief Medical OfficerHennigsdorf/Berlin (...

Global Roundup: UCB Snaps Up Rare Disease Company Zogenix

Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

MD Anderson and Eisbach Bio collaborate to develop precision oncology drugs

The University of Texas MD Anderson Cancer Center and Eisbach Bio GmbH today announced a strategic research collaboration to jointly discover and develop precision oncology drugs that target synthetic lethal engines key to tumor genome evolution.

MD Anderson and Eisbach Bio announce strategic collaboration to develop medicines targeting epigenetic machinery

The University of Texas MD Anderson Cancer Center and Eisbach Bio GmbH today announced a strategic research collaboration to jointly discover and

Eisbach Bio Receives EUR 8 Million Government Grant to Progress COVID-19 Antiviral Through Phase I/II Clinical Development